Review
Sep 2026
Decoding dysbiosis: the role of gut microbiota in MASLD progression and emerging therapeutic interventions
The gut microbiota–liver axis plays a central role in the pathogenesis of MASLD and emerging modalities within microbiome-based therapies, including mesenchymal stromal cell therapy and bacteriophage therapy, offer potential for targeted modulation of the gut microbiota and liver repair.
Dinesh Mohan Swamikkannu, Santhosha Dasarapu, K. Mohan et al.
· Journal of physiology and bi... · 0 citations